MAGNIFICAT project: dual user and harm reduction potential
On 19th January, in Hotel Palace Catania, there was a Kick-Off meeting held by CoEHAR, its Partners: ABF GmbH from Germany, PRATIA MTZ from Poland and supporting Parties such as…
CoEHAR teams up with US expert to refute ecig study
The COEHAR founder, prof. Riccardo Polosa, in collaboration with experts from US (Floe Foxon, Ray S. Niaura, K. Michael Cummings, Michael Siegel and Neal Benowitz) published a commentary to analyze data and methodologies used to support the paper’s conclusions.
CoEHAR: 22 members among the world’s most cited scientists
However, this year, in addition to Professor Polosa, 21 researchers from the Center of Excellence for the acceleration of Harm Reduction of the University of Catania are honored for their work and included in the database. They are: Sebastiano Battiato, Antonino Belfiore, Maria Luisa Brandi, Aldo Calogero, Filippo Caraci, Rosita A. Condorelli, Filippo Drago, Margherita Ferrante, Antonio Gagliano, Fabio Galvano, Giuseppe Grasso, Antonino Gulino, Gaetano Isola, Emmanuele Jannini, Rosalia Maria Leonardi, Sandro La Vignera, Giovanni Li Volti, Gea Oliveri Conti, Eugenio Pedullà, Venerando Rapisarda, Martino Ruggieri.
WhatsApp Image 2023-11-21 at 13.43.34
Unveiling the truth of aerosol emission: far fewer hazardous compounds in heated tobacco products than in cigarette smoke
“ Our comprehensive analysis underscores that the aerosol from heated tobacco products (HTPs) contains markedly fewer and substantially lower concentrations of toxic compounds compared to traditional cigarette smoke," Professor Roberto Sussman, first author of the study, stated. "However, despite the reduced levels, the existence of harmful compounds in HTPs and e-cigarettes, notably aldehydes, necessitates vigilant oversight."
BREAKTHROUGH STUDY REVEALS VARENICLINE AND COUNSELING EFFECTIVE FOR DUAL USERS IN SMOKING CESSATION
The study found that the antismoking medication varenicline can increase rates of smoking abstinence without causing serious adverse events.
CoEHAR: NO HEALTH RESPIRATORY EFFECTS REPORTED WITH ECIG SUBSTITUTION FOR SMOKING
In their work “Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review”, researchers analyzed 16 studies from 20 publications: most of the studies showed no difference in respiratory parameters. This indicates that electronic nicotine delivery systems substitution for smoking likely does not result in additional harm to respiratory health.
In Silico Science and Replica PI will attend the 6th THR summit, Athens
Two CoEHAR researchers will be part of this great event: The CoEHAR Director, Giovanni Li Volti, who is also PI of the replica project, will discuss the latest results of the Replica project and the IN silicon Science Pi, Dr. Renée O’Leary, will present her latest work.
REPLICA STUDY: CoEHAR research shows minimal to zero cancerogenic effects of e-cigarettes
Replica researchers performed a standard toxicology battery of three assays used for product assessment and regulatory applications.
DiaSmokeFree Working Group Challenges American Diabetes Association Guidelines on E-Cigarette Use
The DiaSmokeFree Working Group send a letter to the American Diabetes Association (ADA) expressing concern and seeking correction of a couple of statements in the ADA guidelines regarding the use…
CoEHAR letter to the European Commissioner for Health for a redefinition of anti-smoking policies
As requested by experts in the letter: "Our hope is that, in light of scientific evidence, the FCTC and the European Union conduct a careful, balanced, and transparent review of the available scientific evidence regarding non-combustible products, compared to conventional cigarettes, to provide indispensable information for making decisions in the interest of millions of smokers."
- Go to the previous page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- …
- 26
- Go to the next page